STAT Plus: Pharmalittle: Hackers linked to Iran sought Gilead Covid-19 data; NIH to test remdesivir with a Lilly drug

The NIH has started a clinical study to test a combination of remdesivir and Olumiant, an anti-inflammatory treatment marketed by Eli Lilly, in coronavirus patients.

Click to view original post